MIRA INFORM REPORT

 

 

Report No. :

352611

Report Date :

07.12.2015

 

IDENTIFICATION DETAILS

 

Name :

OBSHCHESTVO S OGRANICHENNOY OTVETSTVENNOSTYU "E.T.S. FARMA"

 

 

Registered Office :

Proezd Nagornyy D. 12, Kor. 1, 117105 G Moskva

 

 

Country :

Russia

 

 

Financials (as on) :

31.12.2014

 

 

Date of Incorporation :

24.02.2000

 

 

Com. Reg. No.:

1027700020908

 

 

Legal Form :

Limited liability companies

 

 

Line of Business :

  • Agents specializing in the sale of particular products or ranges of products n.e.c
  • Agents involved in the sale of a variety of goods
  • Wholesale of pharmaceutical goods
  • Other retail sale in specialized stores
  • Storage and warehousing
  • Other supporting land transport activities
  • Activities of other transport agencies
  • Market research and public opinion polling

 

 

No. of Employee :

Not Available

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Russia

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

RUSSIA - ECONOMIC OVERVIEW

 

Russia has undergone significant changes since the collapse of the Soviet Union, moving from a globally-isolated, centrally-planned economy towards a more market-based and globally-integrated economy, but stalling as a partially reformed, statist economy with a high concentration of wealth in officials' hands. Economic reforms in the 1990s privatized most industry, with notable exceptions in the energy and defense-related sectors. The protection of property rights is still weak and the private sector remains subject to heavy state interference. Russia is one of the world's leading producers of oil and natural gas, and is also a top exporter of metals such as steel and primary aluminum. Russia's manufacturing sector is generally uncompetitive on world markets and is geared toward domestic consumption. Russia's reliance on commodity exports makes it vulnerable to boom and bust cycles that follow the volatile swings in global prices. The economy, which had averaged 7% growth during 1998-2008 as oil prices rose rapidly, was one of the hardest hit by the 2008-09 global economic crisis as oil prices plummeted and the foreign credits that Russian banks and firms relied on dried up. In 2014, economic growth declined further when Russia forcibly violated Ukraine’s sovereignty and territorial integrity, and interfered in Ukraine’s internal affairs. In the second half of 2014, the Russian ruble lost about half of its value, contributing to increased capital outflows that reached $151.5 billion for the year; the ruble remains volatile. Declining oil prices, lack of economic reforms, and the imposition of foreign sanctions have contributed to the downturn and created wide expectations the economy will continue to slump. In April 2015, the Russian Ministry of Economic Development predicted that the Russia’s economy will contract by 3% in 2015, and average only 2.5% growth through 2030.

 

Source : CIA

 

Company name and address

 

 

OOO "E.T.S. FARMA"
Proezd Nagornyy D. 12, Kor. 1, 117105 G Moskva

Tel: 74955029001
E-Mail: agio@agio-pharma.ru
Web: www.agio-pharma.com

 

 

 

Company SUMMERY

 

Legal form

Limited liability companies (OOO)

 

Established on

24/02/2000 - Limited liability companies (OOO)

 

Registered on

11/07/2002, Upravlenie Ministerstva Rossiyskoy Federatsii po nalogam i sboram po g.Moskve, RegNr.: 1027700020908
Tax number: 7730124019
Statistical number: 52639444

Registered capital

RUB

10 000,-

 

 

Owner

MEZHDUNARODNAYA KOMPANIYA ETS FARMA LIMITED
SHEYKH ZAYED ROUD KHALID AL ATTAR TAUER СВИТ 1003, П.Я. 7124 g Dubay, United Arab Emirates

%

100

 

Sole Executive Body

Svetlana Evgenevna KHarchevnikova
Managing director

 

General data

Main activity:
Agents specializing in the sale of particular products or ranges of products n.e.c.


(51.18.27)

 

Commercial name:
Agio Pharmaceuticals

 

 

Full name:
Obshchestvo s ogranichennoy otvetstvennostyu "E.T.S. FARMA"

 

Short name:
OOO "E.T.S. FARMA"

 

 

 

Residence address:
prospekt Kutuzovskiy d. 20 str. 4 Комнт 18, 121151 g Moskva

 

 

Permanent address:
proezd Nagornyy d. 12, kor. 1, 117105 g Moskva
Tel:
74955029001
E-Mail:
agio@agio-pharma.ru
Web:
www.agio-pharma.com

 

As open sources inform, the main activity of OOO "E.T.S. FARMA" is pharmaceutical retail.

 

Other activities

 

:

 

 

 

Agents specializing in the sale of particular products or ranges of products n.e.c.

(51.18.1)

 

Agents involved in the sale of a variety of goods

(51.19)

 

 

Wholesale of pharmaceutical goods

(51.46.1)

 

Other retail sale in specialized stores

(52.48)

 

 

Storage and warehousing

(63.12.4)

 

Other supporting land transport activities

(63.21)

 

 

Activities of other transport agencies

(63.40)

 

Market research and public opinion polling

(74.13)

 

 

Hospital activities

(85.11)

Annual turnover

31/12/2006

Enterprise turnover

RUB

176 354 000,-

 

 

 

31/12/2007

Enterprise turnover

RUB

241 066 000,-

 

 

31/12/2008

Enterprise turnover

RUB

210 452 000,-

 

 

 

31/12/2009

Enterprise turnover

RUB

230 784 000,-

 

 

31/12/2010

Enterprise turnover

RUB

197 393 000,-

 

 

 

31/12/2011

Enterprise turnover

RUB

253 959 000,-

 

 

31/12/2012

Enterprise turnover

RUB

296 916 000,-

 

 

 

31/12/2013

Enterprise turnover

RUB

301 630 000,-

 

 

31/12/2014

Enterprise turnover

RUB

334 990 000,-

 

 

Remarks

The subject has the following license:
FS-99-02-003626 - Pharmaceutical activity: Wholesale drug for medical use - Unlimited;
FS-99-02-002680 - Pharmaceutical activity: Wholesale drug for medical use - Unlimited;
FS-99-02-000048 - Pharmaceutical activity - Unlimited.
According to the research, affiliation through the director of OOO "E.T.S. FARMA", Svetlana Evgenevna Kharchvnikova, with other legal persons has not been revealed.
OOO "E.T.S. FARMA" has not participated in court cases.
Acсording to information, disclosed by the Federal Tax Service, OOO "E.T.S. FARMA" does not have tax arrears, company is not going to be excluded from the state register as non-active.
According to information, disclosed by the Pension Fund of Russian Federation, OOO "E.T.S. FARMA" does not have delays in social payments.
According to information, disclosed by the Federal Labor Service, OOO "E.T.S. FARMA" does not plan to attract foreign employees.
OOO "E.T.S. FARMA" is not in the list of default debtors, the Register of unfair suppliers, the blacklist of Russian companies.
The management of company is not in the list of default debtors, the register of disqualified persons, the blacklist of Russian Private Persons.
OOO "E.T.S. FARMA" did not participate in court cases.
There is no negative information about company in open sources.

 



Financial statement

 

A. The enclosed balance of 2012 is originated from official source, no data available about authentication. (31.12.2012 - 1000 RUB) - Warning! The figures stated in the balance sheet may contain error(s).
B. The enclosed balance of 2013 is originated from official source, no data available about authentication. (31.12.2013 - 1000 RUB) - Warning! The figures stated in the balance sheet may contain error(s).
C. The enclosed balance of 2014 is originated from official source, no data available about authentication. (31.12.2014 - 1000 RUB) - Warning! The figures stated in the balance sheet may contain error(s).

 

balance

A 31.12.2012

B 31.12.2013

C 31.12.2014

1. ASSETS

 

 

 

I. FIXED ASSETS

 

 

 

Intangible assets

0

0

0

The results of research and development

0

0

0

Intangible research assets

0

0

0

Tangible research assets

0

0

0

Fixed assets

115

107

2 099

Profitable investments in tangible assets

0

0

0

Financial investments

0

0

0

Deferred tax assets

0

0

14 141

Other non-current assets

0

0

0

TOTAL IN SECTION I.

115

107

16 240

II. CURRENT ASSETS

 

 

 

Inventories

23 830

11 465

31 445

VAT on acquired assets

202

1

304

Accounts receivable

112 982

40 212

41 267

Financial investments (excluding the monetary equivalent)

0

0

0

Cash and monetary equivalents

1 689

891

42

Other current assets

166

197

352

TOTAL IN SECTION II.

138 869

52 766

73 410

BALANCE

138 984

52 879

89 650

2. LIABILITIES

 

 

 

III. CAPITAL AND RESERVES

 

 

 

Authorized capital (share capital, charter capital, deposits capital, partners capital)

10

10

10

Treasury stock

0

0

0

Revaluation of fixed assets

0

0

0

Additional capital (without revaluation)

0

0

0

Reserve capital

0

0

0

Retained earnings (uncovered loss)

-39 791

-64 345

-108 698

TOTAL IN SECTION III.

-39 781

-64 335

-108 688

IV. LONG-TERM LIABILITIES

 

 

 

Borrowed funds

0

0

0

Deferred tax liabilities

0

0

5

Provisions

0

0

0

Other liabilities

0

0

0

TOTAL IN SECTION IV.

0

0

5

V. SHORT-TERM LIABILITIES

 

 

 

Borrowed funds

0

0

0

Payables

178 765

117 066

198 101

Deferred income

0

0

0

Provisions

0

142

232

Sonstige Verbindlichkeiten

0

0

0

TOTAL IN SECTION V.

178 765

117 208

198 333

BALANCE

138 984

52 873

89 650

A. The enclosed profit and loss account of 2012 is originated from official source, no data available about authentication. (31.12.2012 - 1000 RUB)
B. The enclosed profit and loss account of 2013 is originated from official source, no data available about authentication. (31.12.2013 - 1000 RUB)
C. The enclosed profit and loss account of 2014 is originated from official source, no data available about authentication. (31.12.2014 - 1000 RUB)

 

profit and loss account

A 31.12.2012

B 31.12.2013

C 31.12.2014

Turnover

296 916

301 630

334 990

Cost of sales

269 873

265 077

268 732

Gross profit (loss)

27 043

36 553

66 258

Selling expenses

28 075

36 307

29 433

Administrative expenses

0

0

0

Sales profit (loss)

-1 032

246

36 825

Earnings from other entities

0

0

0

Interest receivable

0

0

0

Interest payable

0

0

0

Other operating income

61 530

22 125

33 721

Other operating expenses

50 660

46 925

120 387

Profit (loss) before tax

9 838

-24 554

-49 841

Current profit tax

0

2

8 648

Permanent tax liabilities (assets)

0

0

4 480

Change in deferred tax liabilities

0

0

5

Change in deferred tax assets

0

0

14 141

Different

810

0

0

Net profit (loss)

9 028

-24 552

-44 353

Results of fixed assets revaluation, non-includedin net profit/loss for period

0

0

0

Result of other transactions, non included in net profit/loss for period

0

0

0

Total financial result for period

9 028

-24 552

-44 353

 

 

Ratios

 

2012

2013

2014

 

Current ratio

0,78

0,45

0,37

 

 

Quick ratio

0,64

0,35

0,21

 

Average Collection Period

109

92,69

44,39

 

 

Payables turnover Period

202

204

214

 

Debt ratio

1,29

2,22

2,21

 

 

Equity to total assets ratio

-0,29

-1,22

-1,21

 

Funding ratio

-0,22

-0,55

-0,55

 

 

Return on sales

3,04

-8,14

-13,24

 

Return on Assets

7,49

-25,59

-62,24

 

 

Return on Equity

-20,38

47,16

51,27

 

 

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.66.84

UK Pound

1

Rs.101.04

Euro

1

Rs.73.05

RUB

1

Rs.0.98

Note : Above are approximate rates obtained from sources believed to be correct

 

 

INFORMATION DETAILS

 

Analysis Done by :

KAS

 

 

Report Prepared by :

TRU

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.